Stay updated with breaking news from Intermediate Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared with surgical aortic valve replacement (SAVR), according to findings presented at the American College of Cardiology's Annual Scientific Session.
REDWOOD CITY, Calif., Dec. 10, 2023 -- Jasper Therapeutics, Inc. , a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit to address mast cell...
First Patient Dosed in Phase 1 trial of Briquilimab in Lower-Risk Myelodysplastic SyndromeStrengthened the Board of Directors and Management Team with Multiple Appointments REDWOOD CITY, Calif., Aug....
Key opinion leaders in the field of renal cell carcinoma management discuss the advent of combination immunotherapy in patients with metastatic disease.
The panel closes their discussion with a look at the standards for genetic counseling for patients with non-clear cell RCC.